• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八种用于致癌性人乳头瘤病毒(HPV)型别病毒载量定量的高通量聚合酶链反应(PCR)检测方法的性能评估

Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types.

作者信息

Flores-Munguia Roberto, Siegel Erin, Klimecki Walter T, Giuliano Anna R

机构信息

Arizona Cancer Center, The University of Arizona, Tucson, USA.

出版信息

J Mol Diagn. 2004 May;6(2):115-24. doi: 10.1016/S1525-1578(10)60499-0.

DOI:10.1016/S1525-1578(10)60499-0
PMID:15096567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1867471/
Abstract

Infection with mucosotropic human papillomavirus (HPV) is the necessary cause of cervical intraepithelial neoplasia. Several epidemiological studies suggest that HPV viral load can be a risk factor of cervical dysplasia. The purpose of the present study was to evaluate a methodology to determine HPV viral load of eight oncogenic HPV types (16, 18, 31, 39, 45, 51, 52, and 58). The quantitation assay is based on a high-throughput real-time PCR. The E6-E7 region of HPV types 16, 18, 45, and 51 were used to amplify specific DNA sequences and cloned into a plasmid vector. The constructs for HPV types 16, 18, 45, and 51, and the whole genome for HPV types 31, 39, 52, and 58 were quantitated using a limiting dilution analysis and used to create standard curves. Type-specific HPV clones were used to determine specificity, linearity, and intra- and inter-assay variation. The sensitivity of our assay covered a dynamic range of up to seven orders of magnitude with a coefficient of intra-assay variation less than 6% and the inter-assay variation less than 20%. No cross-reactivity was observed on any of the type-specific standard curves when phylogenetically close HPV types were used as templates. Our real-time PCR methodologies are highly reproducible, sensitive, and specific over a sevenfold magnitude dynamic range.

摘要

嗜黏膜人乳头瘤病毒(HPV)感染是宫颈上皮内瘤变的必要病因。多项流行病学研究表明,HPV病毒载量可能是宫颈发育异常的一个危险因素。本研究的目的是评估一种测定8种致癌性HPV类型(16、18、31、39、45、51、52和58型)病毒载量的方法。定量分析基于高通量实时PCR。使用HPV 16、18、45和51型的E6-E7区域扩增特定DNA序列,并克隆到质粒载体中。使用有限稀释分析法对HPV 16、18、45和51型的构建体以及HPV 31、39、52和58型的全基因组进行定量,并用于创建标准曲线。使用型特异性HPV克隆来确定特异性、线性以及分析内和分析间的变异。我们检测方法的灵敏度覆盖高达7个数量级的动态范围,分析内变异系数小于6%,分析间变异小于20%。当使用亲缘关系相近的HPV类型作为模板时,在任何型特异性标准曲线上均未观察到交叉反应。我们的实时PCR方法在7倍数量级的动态范围内具有高度的可重复性、灵敏性和特异性。

相似文献

1
Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types.八种用于致癌性人乳头瘤病毒(HPV)型别病毒载量定量的高通量聚合酶链反应(PCR)检测方法的性能评估
J Mol Diagn. 2004 May;6(2):115-24. doi: 10.1016/S1525-1578(10)60499-0.
2
Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer.基于实时聚合酶链反应的系统,用于同时定量检测与宫颈癌高风险相关的人乳头瘤病毒类型。
J Clin Microbiol. 2003 Jul;41(7):3221-8. doi: 10.1128/JCM.41.7.3221-3228.2003.
3
Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.宫颈癌发生谱中人乳头瘤病毒16型和58型感染的病毒载量差异
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):730-5. doi: 10.1111/j.1525-1438.2006.00390.x.
4
Spectrum of HPV types before and after treatment of cervical intraepithelial neoplasia grade 2 and 3.HPV 型别在治疗宫颈上皮内瘤变 2 级和 3 级前后的分布。
J Clin Virol. 2017 Dec;97:38-43. doi: 10.1016/j.jcv.2017.10.014. Epub 2017 Nov 3.
5
Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.在大多数宫颈癌中存在来自人乳头瘤病毒16、18、31、33和45型的E6和E7信使核糖核酸。
J Clin Microbiol. 2006 Apr;44(4):1310-7. doi: 10.1128/JCM.44.4.1310-1317.2006.
6
Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?人乳头瘤病毒 DNA 检测(自取样)与医生取样及细胞学检查在发展中国家用于宫颈癌筛查的效果比较如何?
Cancer Epidemiol. 2009 Dec;33(6):446-50. doi: 10.1016/j.canep.2009.10.013. Epub 2009 Nov 20.
7
Changes in type-specific human papillomavirus load predict progression to cervical cancer.特定类型人乳头瘤病毒载量的变化可预测宫颈癌的进展。
J Cell Mol Med. 2012 Dec;16(12):3096-104. doi: 10.1111/j.1582-4934.2012.01631.x.
8
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.用于检测宫颈样本中高危人乳头瘤病毒(HPV)基因型的Digene HC2检测法与罗氏AMPLICOR人乳头瘤病毒(HPV)检测法的比较。
J Clin Microbiol. 2006 Jun;44(6):2141-6. doi: 10.1128/JCM.00049-06.
9
Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.比较宫颈样本中致癌 HPV 型特异性病毒 DNA 载量和 E6/E7 mRNA 检测:一项多中心研究的结果。
J Med Virol. 2013 Mar;85(3):472-82. doi: 10.1002/jmv.23487. Epub 2012 Dec 26.
10
Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.在转诊人群中,基于 HPV 型别和病毒载量的 AnyPlex II HPV28 的临床性能。
PLoS One. 2019 Jan 23;14(1):e0210997. doi: 10.1371/journal.pone.0210997. eCollection 2019.

引用本文的文献

1
Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.东亚、东南亚和南亚地区人乳头瘤病毒(HPV)致癌类型的最新进展
Cancers (Basel). 2021 May 30;13(11):2691. doi: 10.3390/cancers13112691.
2
Prevalence of Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology.近期宫颈细胞学异常的意大利女性感染、血清型分布及七种高危型 HPV 共同感染的流行情况。
Int J Environ Res Public Health. 2019 Sep 11;16(18):3354. doi: 10.3390/ijerph16183354.
3
HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.在中国西南部,HPV-16、HPV-58 和 HPV-33 是致癌性最强的 HPV 基因型,其病毒载量与宫颈前病变的严重程度相关。
Virol J. 2018 May 25;15(1):94. doi: 10.1186/s12985-018-1003-x.
4
Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia.近期有低度或癌前宫颈发育异常病史的女性血浆和宫颈样本中人乳头瘤病毒DNA检测
PLoS One. 2017 Nov 28;12(11):e0188592. doi: 10.1371/journal.pone.0188592. eCollection 2017.
5
Laboratory and clinical aspects of human papillomavirus testing.人乳头瘤病毒检测的实验室和临床方面。
Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174.
6
Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.意大利撒丁岛北部地区女性人群中 HPV 感染的流行率和型别分布。
BMC Public Health. 2011 Oct 11;11:785. doi: 10.1186/1471-2458-11-785.
7
Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.原位杂交法检测组织学样本中的人乳头瘤病毒(HPV):与细胞学改变及聚合酶链反应 HPV 检测的相关性。
Am J Clin Pathol. 2011 Jul;136(1):119-27. doi: 10.1309/AJCP03HUQYZMWATP.
8
Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.评估一种商业化的原位杂交检测方法,用于检测宫颈上皮内瘤变和宫颈癌患者组织标本中的人乳头瘤病毒DNA。
J Clin Microbiol. 2008 Jan;46(1):274-80. doi: 10.1128/JCM.01299-07. Epub 2007 Oct 31.

本文引用的文献

1
Viral load as a predictor of the risk of cervical intraepithelial neoplasia.病毒载量作为宫颈上皮内瘤变风险的预测指标。
Int J Cancer. 2003 Feb 10;103(4):519-24. doi: 10.1002/ijc.10846.
2
Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.用于定量生物体液中人疱疹病毒8型DNA的校准实时PCR检测法。
J Clin Microbiol. 2002 Dec;40(12):4652-8. doi: 10.1128/JCM.40.12.4652-4658.2002.
3
Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.子宫颈原位癌中HPV 16滴度的宿主基因控制
Int J Cancer. 2002 Oct 20;101(6):526-31. doi: 10.1002/ijc.90010.
4
Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance.正常和异常宫颈刮片中的人乳头瘤病毒16载量:CIN II/III和病毒清除的一个指标
Int J Cancer. 2002 Apr 1;98(4):590-5. doi: 10.1002/ijc.10232.
5
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.人乳头瘤病毒16型DNA在扁桃体癌中的患病率、分布及病毒载量
Cancer. 2001 Dec 1;92(11):2875-84. doi: 10.1002/1097-0142(20011201)92:11<2875::aid-cncr10130>3.0.co;2-7.
6
Current methods of testing for human papillomavirus.人乳头瘤病毒的现行检测方法。
Best Pract Res Clin Obstet Gynaecol. 2001 Oct;15(5):677-700. doi: 10.1053/beog.2001.0214.
7
Cervical cancer detection by hybrid capture and evaluation of local risk factors.通过杂交捕获法检测宫颈癌并评估局部危险因素。
Int J Gynaecol Obstet. 2001 Apr;73(1):41-6. doi: 10.1016/s0020-7292(00)00390-8.
8
Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe.
J Virol Methods. 2001 Apr;93(1-2):33-42. doi: 10.1016/s0166-0934(00)00288-3.
9
Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18.基于实时聚合酶链反应的荧光检测法用于定量检测人乳头瘤病毒6型、11型、16型和18型
Mol Diagn. 2001 Mar;6(1):39-47. doi: 10.1054/modi.2001.21899.
10
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.意义不明确的非典型鳞状细胞患者三种管理策略的比较:一项随机试验的基线结果。
J Natl Cancer Inst. 2001 Feb 21;93(4):293-9. doi: 10.1093/jnci/93.4.293.